InvestmentNews – Venture capital firm targets RIAs

May 11, 2022
bridge showing venture capital opportunity

High-net-worth clients are interested in private investments. Mammoth Scientific a venture capital firm that just rolled out a venture capital fund, aims to provide such products to the RIA channel, say two of its founders, Jud Mackrill and Tommy Martin.

Mammoth™ Scientific, a health science and technology venture capital firm, announced the launch of a venture capital fund today. Co-founders Dr. Jay YadavTommy MartinKim MackrillDr. Matthew McGirt, and Jud Mackrill provide venture capital for health science and technology companies who are maturing beyond seed rounds. The Mammoth Scientific team includes seasoned physician entrepreneurs and highly successful operational managers, representing a 20-year track record of creating and investing in multiple successful startups with large exits to major global companies (e.g., Abbott Laboratories, Boston Scientific, Johnson & Johnson) or to the public markets.

Mammoth Scientific’s competitive edge comes from its creation of venture capital investment pathways for the highly underserved RIA advisory market. Through proprietary fintech, Mammoth Scientific has integrated groundbreaking 2021 SEC and healthcare investment rules. The U.S. RIA market manages more than $5.7 trillion but has historically been hindered from providing venture capital investments to clients due to regulatory challenges, uncertainty around risk, and how to best engage clients.1 Mammoth Scientific has created a pathway for compliant marketing, sales, and management designed to keep wealth managers at the center of their client relationships.


Mammoth Scientific, Mammoth Private Capital Health and Tech Fund, the Mammoth logo, and the tagline “Invest Beyond the Ordinary” are trademarks of Mammoth Scientific, LLC and are protected by trademark laws of the United States and other countries. All other product and company names are trademarks or registered trademarks of their respective companies.

Venture fund management provided by Mammoth Scientific, LLC, an Exempt Reporting Adviser. Private capital platform services provided by The Securities Group, LLC dba Mammoth Research. Member FINRA/SIPC. Securities offered by Mammoth Scientific have not been registered under the Securities Act of 1933, as amended or the securities laws of any state or other jurisdictions in reliance upon exemptions from registration provided by the Securities Act and Regulation D Rule 506(c) and comparable exemptions. 

Mammoth Scientific is an investment advisor to certain venture capital funds and files as an exempt reporting advisor, but that status does not imply a certain level of skill or training.

View Full Disclosures by Clicking Here

Similar Posts

Mammoth Scientific Selects SS&C for Inaugural VC Fund

Mammoth Scientific Selects SS&C for Inaugural VC Fund

SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that Mammoth Scientific, a health science and technology venture capital firm, has selected SS&C as administrator and technology partner for its inaugural fund. The fund will provide venture capital to health science and technology companies maturing beyond seed rounds.